natgillin/translations-raw huggingface dataset:
On 19 January 2012, the Kingdom of Denmark submitted to the European Chemicals Agency (hereinafter ‘Agency’) a dossier pursuant to Article 69(4) of Regulation (EC) No 1907/2006, in order to initiate the restrictions process in accordance with Articles 69 to 73 of that Regulation (hereinafter ‘Annex XV dossier’).
Kraljevina Danska je 19. januarja 2012 Evropski agenciji za kemikalije (v nadaljnjem besedilu: Agencija) predložila dokumentacijo v skladu s členom 69(4) Uredbe (ES) št. 1907/2006 za začetek postopka za določitev omejitev v skladu s členi 69 do 73 navedene uredbe (v nadaljnjem besedilu: dokumentacija iz Priloge XV).
In that dossier, it was demonstrated that exposure to chromium VI, when contained in leather articles or leather parts of articles coming into contact with the skin, poses a risk to human health.
V navedeni dokumentaciji je bilo dokazano, da izpostavljenost kromu (VI) v usnjenih izdelkih ali usnjenih delih izdelkov, ki pridejo v stik s kožo, pomeni tveganje za zdravje ljudi.
Chromium VI compounds can induce new cases of sensitisation and elicit allergic response.
Kromove (VI) spojine lahko povzročijo nove primere preobčutljivosti in izzovejo alergijske reakcije.
The dossier demonstrates that action on a Union-wide basis is necessary.
Dokumentacija kaže, da so potrebni ukrepi na ravni Unije.
Chromium VI compounds can be formed in leather through the oxidation of chromium III compounds, which are added in some tanning processes to cross-link the collagen subunits in order to increase leather’s dimensional stability, as well as its resistance to mechanical action and heat.
Kromove (VI) spojine lahko nastajajo v usnju z oksidacijo kromovih (III) spojin, ki se dodajajo v nekaterih postopkih strojenja za zamrežitev podenot kolagena zaradi povečanja dimenzionalne stabilnosti usnja ter njegove mehanske in toplotne odpornosti.
According to the Annex XV dossier, the mechanisms of and conditions under which chromium VI is formed are known and most tanneries in the Union have already developed and widely implemented measures in order to control and minimise its formation.
V skladu z dokumentacijo iz Priloge XV so mehanizmi in pogoji za nastajanje kroma (VI) znani, večina strojarjev v Uniji pa je že pripravila in večinoma izvaja ukrepe za nadzor in zmanjšanje njegovega nastajanja.
On 28 November 2012 the Committee for Risk Assessment (hereinafter ‘RAC’) adopted by consensus the opinion on the restriction proposed in the Annex XV dossier.
Odbor za oceno tveganja (v nadaljnjem besedilu: RAC) je 28. novembra 2012 soglasno sprejel mnenje o omejitvi, predlagani v dokumentaciji iz Priloge XV.
According to the RAC opinion, the restriction is the most appropriate Union-wide measure to address the identified risks posed by chromium VI compounds in leather, both in terms of effectiveness and practicability.
Po mnenju RAC je omejitev najprimernejši ukrep na ravni Unije za obravnavanje ugotovljenih tveganj, ki jih predstavljajo kromove (VI) spojine v usnju, tako v smislu učinkovitosti kot izvedljivosti.
However, in its opinion RAC proposed to modify the restriction by deleting the notion of direct and prolonged contact with the skin, originally included in the Annex XV dossier.
Vendar pa je RAC v svojem mnenju predlagal spremembo omejitve, tako da bi se črtal pojem neposrednega in podaljšanega stika s kožo, ki je bil prvotno vključen v dokumentacijo iz Priloge XV.
The proposed restriction focuses on the risk of induction of skin sensitisation related to direct or indirect skin contact with leather articles or leather parts of articles containing chromium VI.
Predlagane omejitve se osredotočajo na tveganje za pojav preobčutljivosti kože, povezane z neposrednim ali posrednim stikom kože z usnjenimi izdelki ali usnjenimi deli izdelkov, ki vsebujejo krom (VI).
In already sensitised people, such contacts may also elicit allergic response at lower concentrations than those needed for the induction of sensitisation.
Pri preobčutljivih ljudeh lahko tak stik povzroči tudi alergijske reakcije že pri nižjih koncentracijah od tistih, ki so potrebne za pojav preobčutljivosti.
The proposed restriction should cover leather articles and articles containing leather parts used by consumers or workers, that under normal or reasonably foreseeable conditions of use come into contact with the skin.
Predlagana omejitev bi morala zajemati usnjene izdelke in izdelke, ki vsebujejo dele iz usnja, ki jih uporabljajo potrošniki ali delavci, ki v običajnih ali razumno predvidljivih pogojih uporabe pridejo v stik s kožo.
The EN ISO 17075 standard method is the only internationally recognised analytical method currently available to detect chromium VI in leather, including leather in articles.
Standardna metoda EN ISO 17075 je edina mednarodno priznana analitska metoda, ki je trenutno na voljo za odkrivanje kroma (VI) v usnju, tudi v izdelkih, ki vsebujejo usnje.
The determination limit of the EN ISO 17075 standard method is 3 mg/kg (0,0003 % by weight) of chromium VI content in the total dry weight of the leather.
Meja določanja pri standardni metodi EN ISO 17075 je 3 mg/kg (0,0003 mas. %) kroma (VI), računano na skupno suho težo usnja.
Fixing such threshold for the restriction of the placing on the market of leather articles or articles containing leather parts is therefore justified for monitorability and enforceability purposes.
Določitev takega praga za omejitev dajanja na trg usnjenih izdelkov ali izdelkov, ki vsebujejo dele iz usnja, je torej utemeljena zaradi možnosti spremljanja in izvrševanja.
According to the RAC opinion, the threshold of 3 mg/kg (0,0003 % by weight) of chromium VI content in the total dry weight of the leather corresponds to exposures higher than the Lowest-Observed Adverse Effect Level for elicitation.
Po mnenju RAC ustreza prag 3 mg/kg (0,0003 mas. %) vsebnosti kroma (VI), računano na skupno suho težo usnja, izpostavljenosti, višji od najnižje ravni z opaženim škodljivim učinkom za sprožitev alergijske reakcije.
According to the opinion of RAC, that threshold is expected to be 80 % effective in reducing the occurrence of new chromium VI-related allergic dermatitis cases due to chromium VI in leather articles.
Po mnenju RAC se pričakuje, da bo navedeni prag z 80-odstotno učinkovitostjo zmanjšal število novih primerov alergijskega dermatitisa, povezanega s prisotnostjo kroma (VI) v usnjenih izdelkih.
The effectiveness of the restriction on the number of cases of chromium allergy can be determined by monitoring cases of chromium VI-related allergic dermatitis.
Učinkovitost omejitve na število primerov alergij na krom se lahko določi s spremljanjem primerov alergijskega dermatitisa, povezanega s kromom (VI).
Should the prevalence of the allergy not decrease, or should an analytical method to detect lower content of chromium VI become available and be recognised as reliable, this restriction should be reviewed.
Če se razširjenost alergij ne bo zmanjšala ali če bo na voljo analitska metoda za odkrivanje nižjih vsebnosti kroma (VI), ki bo priznana kot zanesljiva, bo treba to omejitev znova proučiti.
On 6 March 2013 the Committee for Socio-Economic Analysis (hereinafter ‘SEAC’) adopted by consensus the opinion on the restriction proposed in the Annex XV dossier.
Odbor za socialno-ekonomsko analizo (v nadaljnjem besedilu: SEAC) je 6. marca 2013 soglasno sprejel mnenje o omejitvi, predlagani v dokumentaciji Priloge XV.
According to the SEAC opinion, the restriction, as modified by RAC, is the most appropriate Union-wide measure to address the identified risks in terms of the proportionality of its socioeconomic benefits to its socioeconomic costs.
Po mnenju SEAC je omejitev, kakor jo je spremenil RAC, najprimernejši ukrep na ravni Unije za obravnavanje ugotovljenih tveganj v smislu sorazmernosti socialno-ekonomskih koristi in socialno-ekonomskih stroškov.
The Forum for Exchange of Information on Enforcement was consulted during the restrictions process.
V postopku določanja omejitev so bila opravljena tudi posvetovanja s Forumom za izmenjavo informacij o izvrševanju.
On 8 April 2013 the Agency submitted to the Commission the opinions of RAC and SEAC based on which the Commission concluded that an unacceptable risk to human health arose where chromium VI compounds were present in leather articles and articles containing leather parts, coming into contact with the skin, which needs to be addressed on a Union-wide basis.
Agencija je Komisiji 8. aprila 2013 predložila mnenji RAC in SEAC, na podlagi katerih je Komisija sklenila, da pomeni prisotnost kromovih (VI) spojin v usnjenih izdelkih in izdelkih, ki vsebujejo dele iz usnja, ki pridejo v stik s kožo, nesprejemljivo tveganje za zdravje ljudi, ki ga je treba obravnavati na ravni Unije.
The socioeconomic impacts of this restriction, including the availability of alternatives, have been taken into account.
Socialno-ekonomski učinki te omejitve, vključno z razpoložljivostjo alternativ, so bili upoštevani.
The restriction on the placing on the market of second-hand articles would impose a disproportionate burden on the consumers re-selling these articles.
Omejitev dajanja na trg rabljenih izdelkov bi nesorazmerno obremenilo potrošnike, ki preprodajajo te izdelke.
Furthermore, due to the nature of those transactions, such restriction would be difficult to enforce.
Poleg tega bi bilo zaradi narave navedenih poslov tako omejitev težko izvajati.
Therefore, this restriction should not apply to leather articles or articles containing leather parts which were in end-use in the Union before this Regulation applies.
Zato se ta omejitev ne bi smela uporabljati za usnjene izdelke ali izdelke, ki vsebujejo dele iz usnja, ki so bili v Uniji v končni uporabi pred začetkom uporabe te uredbe.
It is appropriate to provide for a period of 12 months after the entry into force of this Regulation for the stakeholders concerned to take measures to comply with this Regulation, including addressing articles that are already in the supply chain, including in stocks.
Primerno je določiti 12-mesečno obdobje po začetku veljavnosti te uredbe, v katerem lahko zadevni deležniki sprejmejo ukrepe za uskladitev s to uredbo, vključno z obravnavo izdelkov, ki so že v dobavni verigi, tudi v zalogah.
It shall apply from 1 May 2015.
Uporablja se od 1. maja 2015.
Done at Brussels, 25 March 2014.
V Bruslju, 25. marca 2014
In Annex XVII to Regulation (EC) No 1907/2006, the following paragraphs 5, 6 and 7 are added to column 2 of entry 47:
V Prilogi XVII k Uredbi (ES) št. 1907/2006 se v stolpec 2 vnosa 47 dodajo naslednji odstavki 5, 6 in 7:
Leather articles coming into contact with the skin shall not be placed on the market where they contain chromium VI in concentrations equal to or greater than 3 mg/kg (0,0003 % by weight) of the total dry weight of the leather.
Usnjeni izdelki, ki pridejo v stik s kožo, se ne dajo na trg, kadar vsebujejo krom (VI) v koncentracijah, enakih ali večjih od 3 mg/kg (0,0003 mas. %), računano na skupno suho težo usnja.
Articles containing leather parts coming into contact with the skin shall not be placed on the market where any of those leather parts contains chromium VI in concentrations equal to or greater than 3 mg/kg (0,0003 % by weight) of the total dry weight of that leather part.
Izdelki, ki vsebujejo dele iz usnja, ki pridejo v stik s kožo, se ne dajo na trg, kadar kateri koli taki deli vsebujejo krom (VI) v koncentracijah, enakih ali večjih od 3 mg/kg (0,0003 mas. %), računano na skupno suho težo navedenega dela iz usnja.
Paragraphs 5 and 6 shall not apply to the placing on the market of second-hand articles which were in end-use in the Union before 1 May 2015.’
Odstavka 5 in 6 se ne uporabljata za dajanje na trg rabljenih izdelkov, ki so bili v končni uporabi v Uniji pred 1. majem 2015.“
Commission Implementing Regulation (EU) No 302/2014
Izvedbena uredba Komisije (EU) št. 302/2014
concerning the authorisation of a preparation of endo-1,3(4)-beta-glucanase produced by Trichoderma reesei (CBS 126896) as a feed additive for chickens for fattening and weaned piglets (holder of the authorisation ROAL Oy)
o izdaji dovoljenja za pripravek iz endo-1,3(4)-beta-glukanaze, ki jo proizvaja Trichoderma reesei (CBS 126896), kot krmni dodatek za piščance za pitanje in odstavljene pujske (imetnik dovoljenja ROAL Oy)
In accordance with Article 7 of Regulation (EC) No 1831/2003 an application was submitted for the authorisation of a preparation of endo-1,3(4)-beta-glucanase produced by Trichoderma reesei (CBS 126896).
V skladu s členom 7 Uredbe (ES) št. 1831/2003 je bil predložen zahtevek za dovoljenje za pripravek iz endo-1,3(4)-beta-glukanaze, ki jo proizvaja Trichoderma reesei (CBS 126896).
That application concerns the authorisation of a preparation of endo-1,3(4)-beta-glucanase produced by Trichoderma reesei (CBS 126896) as a feed additive for chickens for fattening and weaned piglets, to be classified in the additive category ‘zootechnical additives’.
Zahtevek zadeva izdajo dovoljenja za pripravek iz endo-1,3(4)-beta-glukanaze, ki jo proizvaja Trichoderma reesei (CBS 126896), kot krmni dodatek za piščance za pitanje in odstavljene pujske ter njegovo uvrstitev v kategorijo dodatkov „zootehnični dodatki“.
The European Food Safety Authority (‘the Authority’) concluded in its opinion of 9 October 2013 [2] that, under the proposed conditions of use, the preparation of endo-1,3(4)-beta-glucanase produced by Trichoderma reesei (CBS 126896) does not have an adverse effect on animal health, human health or the environment.
Evropska agencija za varnost hrane (v nadaljnjem besedilu: Agencija) je v svojem mnenju z dne 9. oktobra 2013 [2] navedla, da uporaba pripravka iz endo-1,3(4)-beta-glukanaze, ki jo proizvaja Trichoderma reesei (CBS 126896), pod predlaganimi pogoji uporabe nima škodljivega vpliva na zdravje živali in ljudi ali na okolje.
It also concluded that the additive improves significantly the performance of the animals.
Prav tako je navedla, da dodatek znatno izboljša proizvodnost živali.
The assessment of the preparation of endo-1,3(4)-beta-glucanase produced by Trichoderma reesei (CBS 126896) shows that the conditions for authorisation, as provided for in Article 5 of Regulation (EC) No 1831/2003, are satisfied.
Ocena pripravka iz endo-1,3(4)-beta-glukanaze, ki jo proizvaja Trichoderma reesei (CBS 126896), kaže, da so pogoji za izdajo dovoljenja iz člena 5 Uredbe (ES) št. 1831/2003 izpolnjeni.
Preparation of endo-1,3(4)-beta-glucanase produced by Trichoderma reesei (CBS 126896) having a minimum activity of:
Pripravek iz endo-1,3(4)-beta-glukanaze, ki jo proizvaja Trichoderma reesei (CBS 126896), z najmanjšo aktivnostjo:
solid form: endo-1,3(4)-beta-glucanase 200000 BU [1]/g,
v trdni obliki: endo-1,3(4)-beta-glukanaza 200000 BU [1]/g,
liquid form: endo-1,3(4)-beta-glucanase 400000 BU/ml.
v tekoči obliki: endo-1,3(4)-beta-glukanaza 400000 BU/ml.
endo-1,3(4)-beta-glucanase produced by Trichoderma reesei (CBS 126896)
Endo-1,3(4)-beta-glukanaza, ki jo proizvaja Trichoderma reesei (CBS 126896).
Analytical method [2]For the quantification of endo-1,3(4)-beta-glucanase activity: spectrophotometric (DNS) method, based on the quantification of released sugars produced by the action of endo-1,3(4)-beta-glucanase on barley beta-glucan at pH 4,8 and 50 °C.
Analitska metoda [2]Za kvantifikacijo aktivnosti endo-1,3(4)-beta-glukanaze: spektrofotometrična metoda (DNS), ki temelji na kvantifikaciji sladkorjev, ki se sprostijo med delovanjem endo-1,3(4)-beta-glukanaze na beta-glukan iz ječmena pri pH 4,8 in 50 °C.
15 April 2024
15. april 2024
1 BU is the amount of enzyme which liberates 1 nanomole of reducing sugars (expressed as glucose equivalents) from barley beta-glucan substrate per second at 50 °C and pH 4,8.
1 BU je količina encima, ki sprosti 1 nanomol reduktivnih sladkorjev (izraženo kot ekvivalentov glukoze) iz substrata beta-glukana iz ječmena na sekundo pri 50 °C in pH 4,8.
Commission Implementing Regulation (EU) No 303/2014
Izvedbena uredba Komisije (EU) št. 303/2014
amending Council Regulation (EC) No 673/2005 establishing additional customs duties on imports of certain products originating in the United States of America
o spremembi Uredbe Sveta (ES) št. 673/2005 o vzpostavitvi dodatnih carin za uvoz nekaterih izdelkov s poreklom iz Združenih držav Amerike
The CDSOA disbursements for the most recent year for which data are available relate to the distribution of anti-dumping and countervailing duties collected during the Fiscal Year 2013 (1 October 2012-30 September 2013).
Izplačila po CDSOA za zadnje leto, za katero so podatki na voljo, se nanašajo na razdelitev protidampinških in izravnalnih dajatev, pobranih v proračunskem letu 2013 (od 1. oktobra 2012 do 30. septembra 2013).
On the basis of the data published by the United States’ Customs and Border Protection, the level of nullification or impairment caused to the Union is calculated at USD 872685.
Na podlagi podatkov, ki jih je objavila Carinska in mejna zaščita Združenih držav, je obseg razveljavitev ali omejitev, povzročenih Uniji, preračunan na 872685 USD.
The level of nullification or impairment and consequently of suspension has decreased.
Obseg razveljavitev ali omejitev in posledično stopnja začasnega preklica sta se zmanjšala.
The three products listed in Annex I should therefore be maintained on the list and the rate of additional import duty should be amended and set at 0,35 %.
Zato je tri izdelke na seznamu v Prilogi I treba ohraniti na seznamu, stopnjo dodatne uvozne dajatve pa je treba spremeniti in jo določiti v višini 0,35 %.
The effect of a 0,35 % ad valorem additional import duty on imports from the United States of the products in Annex I represents, over one year, a value of trade that does not exceed USD 872685.
Učinek dodatne uvozne dajatve ad valorem v višini 0,35 % na uvoz izdelkov iz Priloge I iz Združenih držav Amerike predstavlja v času enega leta vrednost trgovine, nižjo od 872685 USD.
To make sure that there are no delays in the application of the amended rate of additional import duty, this Regulation should enter into force on the day of its publication.
Da ne bi prišlo do zamud pri uporabi spremenjene stopnje dodatne uvozne dajatve, mora ta uredba začeti veljati na dan objave.
Regulation (EC) No 673/2005 should therefore be amended accordingly.
Uredbo (ES) št. 673/2005 bi bilo zato treba ustrezno spremeniti.
The measures provided for in this Regulation are in accordance with the opinion delivered by the Committee on Trade Retaliation,
Ukrepi, predvideni v tej uredbi, so v skladu z mnenjem Odbora za povračilne ukrepe v trgovini –
Regulation (EC) No 673/2005 is amended as follows:
Uredba (ES) št. 673/2005 se spremeni:
An ad valorem duty of 0,35 % additional to the customs duty applicable under Council Regulation (EEC) No 2913/92 shall be imposed on the products originating in the United States of America listed in Annex I to this Regulation.(2) Annex I is replaced by the text set out in the Annex to this Regulation.
Za izdelke s poreklom iz Združenih držav Amerike, navedene v Prilogi I k tej uredbi, se poleg carine, ki se uporablja v skladu z Uredbo Sveta (EGS) št. 2913/92, uvede dajatev ad valorem v višini 0,35 %. 2. Priloga I se nadomesti z besedilom iz Priloge k tej uredbi.
The description of products classified under these codes can be found in Annex I to Council Regulation (EEC) No 2658/87 of 23 July 1987 on the tariff and statistical nomenclature and on the Common Customs Tariff as amended by Regulation (EC) No 1810/2004.
Opis izdelkov, ki se uvrščajo pod te oznake, je v Prilogi I k Uredbi Sveta (EGS) št. 2658/87 z dne 23. julija 1987 o tarifni in statistični nomenklaturi ter skupni carinski tarifi, kakor je bila spremenjena z Uredbo (ES) št. 1810/2004.
OJ L 327, 30.10.2004, p. 1.’
UL L 327, 30.10.2004, str. 1.“
As a result of the United States’ failure to bring the Continued Dumping and Subsidy Offset Act (CDSOA) in compliance with its obligations under the World Trade Organization (WTO) agreements, Regulation (EC) No 673/2005 imposed a 15 % ad valorem additional customs duty on imports of certain products originating in the United States of America as from 1 May 2005.
Ker Združene države Amerike niso uskladile Zakona o trajnem dampingu in izravnavi s subvencijami („CDSOA“) s svojimi obveznostmi iz sporazumov Svetovne trgovinske organizacije (STO), je bila z Uredbo (ES) št. 673/2005 s 1. majem 2005 uvedena dodatna carina ad valorem v višini 15 % za uvoz nekaterih izdelkov s poreklom iz Združenih držav Amerike.
Commission Implementing Regulation (EU) No 304/2014
Izvedbena uredba Komisije (EU) št. 304/2014
concerning the authorisation of the preparations of Enterococcus faecium NCIMB 10415, Enterococcus faecium DSM 22502 and Pediococcus acidilactici CNCM I-3237 as feed additives for all animal species
o izdaji dovoljenja za pripravke Enterococcus faecium NCIMB 10415, Enterococcus faecium DSM 22502 in Pediococcus acidilactici CNCM I-3237 kot krmne dodatke za vse živalske vrste
In accordance with Article 10(1)(b) of Regulation (EC) No 1831/2003, the preparations of Enterococcus faecium NCIMB 10415, Enterococcus faecium DSM 22502 and Pediococcus acidilactici CNCM I-3237 were entered in the Register of Feed Additives as existing products belonging to the functional group of silage additives, for all animal species.
V skladu s členom 10(1)(b) Uredbe (ES) št. 1831/2003 so bili pripravki Enterococcus faecium NCIMB 10415, Enterococcus faecium DSM 22502 in Pediococcus acidilactici CNCM I-3237 vpisani v register krmnih dodatkov kot obstoječi proizvodi iz funkcionalne skupine silirnih dodatkov za vse živalske vrste.
In accordance with Article 10(2) of Regulation (EC) No 1831/2003 in conjunction with Article 7 thereof, applications were submitted for the authorisation of those preparations as feed additives for all animal species, requesting those additives to be classified in the category ‘technological additives’ and in the functional group ‘silage additives’.
V skladu s členom 10(2) Uredbe (ES) št. 1831/2003 in v povezavi s členom 7 navedene uredbe so bili vloženi zahtevki za izdajo dovoljenja za navedene pripravke kot krmne dodatke za vse živalske vrste ter za njihovo uvrstitev v kategorijo „tehnološki dodatki“ in funkcionalno skupino „silirni dodatki“.
The European Food Safety Authority (‘the Authority’) concluded in its opinions of 23 May 2012 [2], 10 September 2013 [3] and 10 October 2013 [4] that, under the proposed conditions of use, the preparations concerned do not have an adverse effect on animal health, human health or the environment.
Evropska agencija za varnost hrane (v nadaljnjem besedilu: Agencija) je v svojih mnenjih z dne 23. maja 2012 [2], 10. septembra 2013 [3] in 10. oktobra 2013 [4] navedla, da zadevni pripravki pod predlaganimi pogoji uporabe nimajo škodljivega vpliva na zdravje živali in ljudi ali na okolje.
The Authority also concluded that the preparations of Enterococcus faecium NCIMB 10415, Enterococcus faecium DSM 22502 and Pediococcus acidilactici CNCM I-3237 have the potential to improve the production of silage.
Agencija je tudi ugotovila, da pripravki Enterococcus faecium NCIMB 10415, Enterococcus faecium DSM 22502 in Pediococcus acidilactici CNCM I-3237 lahko izboljšajo proizvodnjo silaže.
The preparations specified in the Annex and feed containing them, which are produced and labelled before 15 October 2014 in accordance with the rules applicable before 15 April 2014 may continue to be placed on the market and used until the existing stocks are exhausted.
Pripravki iz Priloge in krma, ki vsebuje te pripravke, proizvedene in označene pred 15. oktobrom 2014 v skladu s pravili, ki se uporabljajo pred 15. oktobrom 2014, se lahko še naprej dajejo na trg in uporabljajo do porabe obstoječih zalog.
NCIMB 10415 containing a minimum of 1 × 1010 CFU/g additive.
NCIMB 10415 z najnižjo vsebnostjo 1 × 1010 CFU/g dodatka
Viable cells of Enterococcus faecium
žive celice Enterococcus faecium
Analytical method [1]Enumeration in the feed additive: spread plate method using Bile Esculine Azide agar (EN 15788).
Analitska metoda [1]Metoda štetja pri krmnem dodatku: metoda razmaza na plošči z uporabo žolčnega eskulin azidnega agarja (EN 15788).